William Simonds is an Endocrinologist in Baltimore, Maryland. Dr. Simonds is rated as an Elite provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia, Parathyroid Adenoma, Parathyroidectomy, and Thymectomy.

Dr. Douglas Ball is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in oncology. His areas of clinical expertise include diagnostic radiology, endocrine oncology, thyroid cancer and thyroid diseases. Dr. Ball earned his M.D. from the George Washington University School of Medicine. He completed his residency at the University of Pittsburgh-Presbyterian University Hospital and performed a fellowship in endocrinology and metabolism at Johns Hopkins. His research interests include medullary thyroid cancer, differentiated thyroid cancer and anaplastic thyroid cancer. Dr. Ball is rated as an Advanced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Medullary Thyroid Carcinoma, Thyroid Cancer, Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, and Thyroidectomy.

Lilah Morris-Wiseman, M.D., F.A.C.S., is an endocrine surgeon who serves as chief of the Division of Endocrine Surgery. Dr. Morris-Wiseman came to Johns Hopkins in 2021 from the University of Arizona College of Medicine where she was an Associate Professor of Endocrine Surgery. She has a broad endocrine surgery practice using minimally invasive techniques as appropriate to facilitate excellent clinical outcomes with rapid patient recovery. Her clinical practice emphasizes patient-centered shared decision-making and excellent communication and multidisciplinary collaboration so that a patient’s surgical care occurs within an individualized context. She has been named an associate member of the American College of Surgeons' Academy of Master Surgeon Educators. Awardees are recognized for having devoted their careers to surgical education and are considered premier leaders in their respective fields. Dr. Morris-Wiseman holds committee responsibilities with multiple national organizations including the American Thyroid Association, the American Association of Endocrine Surgeons, and the Association of Program Directors in Surgery. She serves on the editorial board of Clinical Thyroidology, is a reviewer for multiple journals, and has published over 50 peer-reviewed manuscripts and book chapters. Dr. Morris-Wiseman sees patients at the Johns Hopkins Outpatient Center in Baltimore and the Johns Hopkins Health Care & Surgery Center – Green Spring Station in Lutherville. To support Dr. Morris-Wiseman's research, visit: https://secure.jhu.edu/form/morris-wiseman. Dr. Morris is rated as an Advanced provider by MediFind in the treatment of Parathyroid Cancer. Her top areas of expertise are Hyperparathyroidism, Familial Isolated Hyperparathyroidism, Osteitis Fibrosa, Thyroidectomy, and Parathyroidectomy.

Dr. Anatoliy Rudin is a distinguished endocrine surgeon and Assistant Professor in the Department of Surgery, Division of Surgical Oncology. With a specialization in the treatment of thyroid, parathyroid, and adrenal diseases, Dr. Rudin brings a wealth of experience and expertise to his practice. He completed his General Surgery residency at the Mayo Clinic in Rochester, MN, followed by an Endocrine Surgery Fellowship at the Cleveland Clinic in Cleveland, OH. Dr. Rudin's research interest is dedicated to improving surgical outcomes through the integration of emerging technologies, advanced imaging, and minimally invasive techniques. His contributions to the field are well-documented through multiple publications and book chapters. Additionally, he has extensive leadership experience and holds committee responsibilities with organizations, including the American Association of Endocrine Surgeons. In his clinical practice, Dr. Rudin provides comprehensive surgical evaluations for patients with endocrine disorders and cancer. He employs a variety of diagnostic techniques, including ultrasound, fine needle aspiration, cytology, and molecular testing, to ensure accurate diagnosis and assessment. Dr. Rudin is adept in the latest surgical techniques, including robotic surgery, and offers personalized treatment options for thyroid, parathyroid, and adrenal diseases. He is committed to a holistic approach to patient care, working closely with individuals to develop tailored treatment plans that address their unique needs. Currently, Dr. Rudin sees patients at the Johns Hopkins Howard County Medical Center. Dr. Rudin is rated as an Advanced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Hyperparathyroidism, Parathyroid Adenoma, Parathyroid Cancer, Parathyroidectomy, and Thyroidectomy.

Jon Russell is an Otolaryngologist in Columbia, Maryland. Dr. Russell is rated as an Advanced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Thyroid Nodule, Thyroidectomy, and Parathyroidectomy.

Douglas Turner is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Turner is rated as an Advanced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Thyroid Cancer, Hyperparathyroidism, Follicular Thyroid Cancer, Thyroidectomy, and Parathyroidectomy.

Otolaryngologist Vaninder “Vinny” K. Dhillon specializes in endocrine surgery, laryngology, otolaryngology, parathyroid diseases and surgery, swallowing disorders, thyroid diseases and surgery, and voice problems. She treats both children and adults. After earning her medical degree from Keck School of Medicine of the University of Southern California, Dr. Dhillon completed a residency in otolaryngology at Los Angeles County and University of Southern California Medical Center. Dr. Dhillon’s research interests include the role of voice outcomes in patients after thyroid and parathyroid surgery when there is concern for vocal fold weakness or paralysis, evaluation of the role of office-based treatment on vocal fold paralysis, as well as neurogenic recovery of vocal fold paralysis. Dr. Dhillon is also interested in treatments for neurogenic chronic cough, which is refractory to other medical intervention. Dr. Dhillon is rated as an Experienced provider by MediFind in the treatment of Parathyroid Cancer. Her top areas of expertise are Laryngeal Nerve Damage, Spasmodic Dysphonia, Neurofibromatosis Type 2 (NF2), Thyroidectomy, and Parathyroidectomy.

Maie John is an Otolaryngologist in Baltimore, Maryland. Dr. John is rated as an Experienced provider by MediFind in the treatment of Parathyroid Cancer. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Melanoma, Glossectomy, and Gastrostomy.

Wojtek Mydlarz, director of Johns Hopkins Head and Neck Surgery in the National Capital Region, specializes in the treatment of benign and malignant tumors of the head and neck, including the upper aerodigestive tract, salivary glands, skull base, thyroid, skin and soft tissue. Dr. Mydlarz is a medical officer and a clinical and research collaborator in the head and neck surgery branch of the National Institutes of Health (NIH). His research interests include evaluating both surgical and nonsurgical treatment outcomes in patients with head and neck cancer. He is interested in the complex molecular biology of head and neck cancer, as well as potential clinical applications of novel targeted cancer therapies. He is actively involved in clinical trial development and implementation at the NIH and Johns Hopkins. After earning his medical degree from the Johns Hopkins University School of Medicine, Dr. Mydlarz completed his internship and residency in otolaryngology–head and neck surgery at The Johns Hopkins Hospital. Additionally, he completed a Science of Clinical Investigation Training Program at Johns Hopkins Bloomberg School of Public Health and specialized fellowship training in head and neck surgical oncology at the University of Texas MD Anderson Cancer Center. Dr. Mydlarz has contributed to numerous professional publications, authored a variety of articles and book chapters, and has been invited to give many lectures. He serves on the editorial board for Oral Oncology and Laryngoscope Investigative Otolaryngology, and is a journal reviewer for Oral Oncology, Head and Neck, Laryngoscope and JAMA Otolaryngology–Head and Neck Surgery. Dr. Mydlarz is rated as an Experienced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Salivary Gland Tumors, Laryngectomy, and Glossectomy.

David S. Cooper, MD, MACP is a graduate of the Tufts University School of Medicine and completed his endocrinology training at Massachusetts General Hospital and Harvard Medical School. He is currently Professor of Medicine and Radiology at the Johns Hopkins University School of Medicine and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. He is one of the editors of the iconic textbook on thyroid disease, Werner and Ingbar’s The Thyroid, and he co-edits two other textbooks: Medical Management of Thyroid Disease and Thyroid Cancer. He is also the co-author of a book for patients with thyroid disease entitled Your Thyroid: A Home Reference. He is the past Chair of the Subspecialty Board for Endocrinology, Diabetes, and Metabolism of the American Board of Internal Medicine. He is an Editor-in-Chief for Endocrinology at Up-to-Date, and he has served as the Chair of the Endocrine Society’s annual Board Review Course. Dr. Cooper was the Chair of the American Thyroid Association’s (ATA) 2006 and 2009 task forces that first drafted clinical practice guidelines for the management of thyroid nodules and thyroid cancer. He also served on ATA sponsored task forces that promulgated guidelines for the management of hypothyroidism and for the management of hyperthyroidism. He is the past Treasurer and past President of the ATA, and the recipient of the ATA’s Distinguished Service Award, its Paul Starr Award, and the Lewis Braverman Lectureship Award. He is also the recipient of the Distinction in Endocrinology Award given by the American Association of Clinical Endocrinologists, as well as the Endocrine Society’s Outstanding Scholarly Physician Laureate Award and the Outstanding Educator Laureate Award. Dr. Cooper is rated as an Experienced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Thyroid Cancer, Graves Disease, Follicular Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Mihail “Misha” Zilbermint, M.D., M.B.A., F.A.C.E. is an Associate Professor of Clinical Medicine at the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine. He is the Director of Endocrine Hospitalists at the Johns Hopkins Community Physicians, Chief and Director of Division of Endocrinology, Diabetes and Metabolism at Suburban Hospital in Bethesda, MD. Dr. Zilbermint is known for pioneering the Endocrine Hospitalist program at Johns Hopkins Medicine following the completion of his endocrinology fellowship at the National Institutes of Health. This consultation service is dedicated to enhancing glycemic control among hospitalized patients, effectively reducing patient stays and saving the hospital hundreds of thousands of dollars. His commitment to innovation earned his specialized diabetes team the Johns Hopkins Innovations in Clinical Care Award. Over the years, Dr. Zilbermint has been sought after for his expertise in endocrinology and diabetes, with a focus on inpatient diabetes management, diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and diabetes technology. His reputation extends nationally and internationally, as he is often invited to speak at conferences and is sought after for consultations worldwide. His extensive research interests encompass diabetes initiatives, hypoglycemia reduction, continuous glucose monitoring (CGM) systems, COVID-19 vaccines and hyperglycemia, COVID-19 and diabetes, genetic causes of hypertension, primary aldosteronism, rare adrenal tumors, and the interplay between diabetes and climate change. Dr. Zilbermint leads the JHCP Academy Clinical Excellence, which helps to recognize and promote clinical excellence about community-based clinicians. Beyond his clinical and research contributions, Dr. Zilbermint is a dedicated educator. He imparts his expertise to endocrinology fellows, hospitalists, pharmacy residents, and advanced practice providers, furthering the advancement of the medical community. CVhttps://www.hopkinsmedicine.org/-/media/profiles-support/cvs/zilbermint.pdfLinkedInhttps://www.linkedin.com/in/mishazilbermint. Dr. Zilbermint is rated as an Experienced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Cushing's syndrome, Familial Hyperaldosteronism, Hyperaldosteronism, Low Blood Sugar, and Thymectomy.

Lee Weinstein is an Endocrinologist in Bethesda, Maryland. Dr. Weinstein is rated as an Advanced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Multiple Endocrine Neoplasia, Multiple Endocrine Neoplasia Type 1, Albright's Hereditary Osteodystrophy, Parathyroidectomy, and Thymectomy.

Armando Sardi is a Surgical Oncologist in Baltimore, Maryland. Dr. Sardi is rated as an Advanced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Pseudomyxoma Peritonei, Colorectal Cancer, Familial Colorectal Cancer, Ureteroscopy, and Hernia Surgery. Dr. Sardi is currently accepting new patients.

Thanh Hoang is an Endocrinologist in Bethesda, Maryland. Dr. Hoang is rated as an Advanced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Hypothyroidism, Thyroid Nodule, Hyperthyroidism, Hormone Replacement Therapy (HRT), and Thyroidectomy.

Juvenal Goicochea is a General Surgeon in Bethesda, Maryland. Dr. Goicochea is rated as an Advanced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Thyroid Cancer, Anaplastic Thyroid Cancer, Follicular Thyroid Cancer, and Parathyroid Adenoma.

Juan Pardo is an Otolaryngologist and an Allergy and Immunologist in Annapolis, Maryland. Dr. Pardo is rated as an Advanced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Infant Hearing Loss, Low Nasal Bridge, Nasal Septal Hematoma, and Trachoma. Dr. Pardo is currently accepting new patients.

Kevin Stitely is a Vascular Surgeon and a General Surgeon in Easton, Maryland. Dr. Stitely is rated as an Advanced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Hernia, Umbilical Hernia, Diverticular Disease, Ileostomy, and Hernia Surgery. Dr. Stitely is currently accepting new patients.

Katherine Day is an Otolaryngologist in Bel Air, Maryland. Dr. Day is rated as an Advanced provider by MediFind in the treatment of Parathyroid Cancer. Her top areas of expertise are Infant Hearing Loss, Jones Syndrome, DFNB1, Gastrostomy, and Endoscopy. Dr. Day is currently accepting new patients.

Joel Turner is a General Surgeon in Baltimore, Maryland. Dr. Turner is rated as an Advanced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Hyperparathyroidism, Osteitis Fibrosa, Neonatal Severe Hyperparathyroidism, Familial Isolated Hyperparathyroidism, and Hernia Surgery. Dr. Turner is currently accepting new patients.

Arun Mavanur is a Surgical Oncologist in Baltimore, Maryland. Dr. Mavanur is rated as an Advanced provider by MediFind in the treatment of Parathyroid Cancer. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Pancreatic Cancer, Pancreatectomy, and Thyroidectomy.